Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more
Park Ha Biological Technology Co., Ltd. (BYAH) - Total Assets
Latest total assets as of April 2025: $5.83 Million USD
Based on the latest financial reports, Park Ha Biological Technology Co., Ltd. (BYAH) holds total assets worth $5.83 Million USD as of April 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Park Ha Biological Technology Co., Ltd. - Total Assets Trend (2021–2024)
This chart illustrates how Park Ha Biological Technology Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Park Ha Biological Technology Co., Ltd. - Asset Composition Analysis
Current Asset Composition (October 2024)
Park Ha Biological Technology Co., Ltd.'s total assets of $5.83 Million consist of 92.3% current assets and 7.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.8% |
| Accounts Receivable | $1.11 Million | 36.0% |
| Inventory | $71.49K | 2.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.62K | 0.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Park Ha Biological Technology Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Park Ha Biological Technology Co., Ltd.'s current assets represent 92.3% of total assets in 2024, an increase from 79.7% in 2021.
- Cash Position: Cash and equivalents constituted 17.8% of total assets in 2024, up from 12.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 36.0% of total assets.
Park Ha Biological Technology Co., Ltd. Competitors by Total Assets
Key competitors of Park Ha Biological Technology Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
|
Amore Group
KO:002790
|
Korea | ₩8.54 Trillion |
Park Ha Biological Technology Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Park Ha Biological Technology Co., Ltd. generates 0.77x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Park Ha Biological Technology Co., Ltd. generates $ 15.52 in net profit.
Park Ha Biological Technology Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.68 | 1.71 | 1.71 |
| Quick Ratio | 3.63 | 1.62 | 1.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.07 Million | $ 758.54K | $ 758.54K |
Park Ha Biological Technology Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Park Ha Biological Technology Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.83 |
| Latest Market Cap to Assets Ratio | 3.81 |
| Asset Growth Rate (YoY) | 36.1% |
| Total Assets | $3.08 Million |
| Market Capitalization | $11.76 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Park Ha Biological Technology Co., Ltd.'s assets at a significant premium ( 3.81x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Park Ha Biological Technology Co., Ltd.'s assets grew by 36.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Park Ha Biological Technology Co., Ltd. (2021–2024)
The table below shows the annual total assets of Park Ha Biological Technology Co., Ltd. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-10-31 | $3.08 Million | +36.14% |
| 2023-10-31 | $2.26 Million | -10.08% |
| 2022-10-31 | $2.52 Million | +323.87% |
| 2021-10-31 | $594.22K | -- |